Molecular classification of serous ovarian cancer subtypes

被引:0
|
作者
Quackenbush, John
Fan, Jian-Bing
Hirsch, Michelle
Mar, Jessica
Howe, Eleanor
Holton, Kristina
Rubio, Renee
April, Craig
Chen, Jing
Wickham-Garcia, Eliza
Liu, Joyce
Culhane, Aedin
Drapkin, Ronny
Matulonis, Ursula
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Illumina Inc, San Diego, CA USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1441
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Clonality and loss of heterozygosity are associated with prognosis and subtypes in high grade serous ovarian cancer
    Takaya, Hisamitsu
    Nakai, Hidekatsu
    Sakai, Kazuko
    Nishio, Kazuto
    Matsumura, Noriomi
    CANCER SCIENCE, 2018, 109 : 640 - 640
  • [32] Gene expression subtypes of high grade serous ovarian cancer in African American women
    Doherty, Jennifer A.
    Greene, Casey S.
    Rudd, James E.
    Tafe, Laura J.
    Alberg, Anthony J.
    Bandera, Elisa V.
    Barnholtz-Sloan, Jill
    Bondy, Melissa
    Cote, Michele L.
    Funkhouser, Ellen
    Moorman, Patricia G.
    Peters, Edward S.
    Schwartz, Ann G.
    Terry, Paul
    Bentley, Rex
    Berchuck, Andrew
    Marks, Jeffrey R.
    Schildkraut, Joellen M.
    CANCER RESEARCH, 2016, 76
  • [33] High-grade serous ovarian cancer subtypes are similar across diverse populations
    Way, Gregory P.
    Rudd, James
    Greene, Casey S.
    Doherty, Jennifer A.
    CANCER RESEARCH, 2015, 75
  • [34] A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression
    Feng, Zheng
    Wen, Hao
    Bi, Rui
    Ju, Xingzhu
    Chen, Xiaojun
    Yang, Wentao
    Wu, Xiaohua
    SCIENTIFIC REPORTS, 2016, 6
  • [35] A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression
    Zheng Feng
    Hao Wen
    Rui Bi
    Xingzhu Ju
    Xiaojun Chen
    Wentao Yang
    Xiaohua Wu
    Scientific Reports, 6
  • [36] Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma
    Hollis, Robert L. L.
    Thomson, John P. P.
    van Baal, Juliette
    Ilenkovan, Narthana
    Churchman, Michael
    van de Vijver, Koen
    Dijk, Frederike
    Meynert, Alison M. M.
    Bartos, Clare
    Rye, Tzyvia
    Croy, Ian
    Diana, Patricia
    van Gent, Mignon
    Creedon, Helen
    Nirsimloo, Rachel
    Lok, Christianne
    Gourley, Charlie
    Herrington, C. Simon
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [37] Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma
    Robert L. Hollis
    John P. Thomson
    Juliette van Baal
    Narthana Ilenkovan
    Michael Churchman
    Koen van de Vijver
    Frederike Dijk
    Alison M. Meynert
    Clare Bartos
    Tzyvia Rye
    Ian Croy
    Patricia Diana
    Mignon van Gent
    Helen Creedon
    Rachel Nirsimloo
    Christianne Lok
    Charlie Gourley
    C. Simon Herrington
    Scientific Reports, 13
  • [38] PrOTYPE (Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE): The development and validation of a clinical-grade consensus classifier for the molecular subtypes of high-grade serous tubo-ovarian cancer.
    Talhouk, Aline
    George, Joshy
    Wang, Chen
    Goode, Ellen
    Ramus, Susan
    Doherty, Jennifer
    Bowtell, David
    Anglesio, Michael
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 38 - 38
  • [39] Subtypes of Ovarian Cancer and Ovarian Cancer Screening
    Koshiyama, Masafumi
    Matsumura, Noriomi
    Konishi, Ikuo
    DIAGNOSTICS, 2017, 7 (01):
  • [40] Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer
    McDonald, Megan E.
    Salinas, Erin A.
    Devor, Eric J.
    Newtson, Andreea M.
    Thiel, Kristina W.
    Goodheart, Michael J.
    Bender, David P.
    Smith, Brian J.
    Leslie, Kimberly K.
    Gonzalez-Bosquet, Jesus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (05):